Edwards Lifesciences Corp financial data

Symbol
EW on NYSE
Location
Irvine, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 432% % 21%
Quick Ratio 76% % -1.9%
Debt-to-equity 29% % -21%
Return On Equity 13% % -75%
Return On Assets 10% % -74%
Operating Margin 24% % -5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 580,300,000 shares -1.6%
Common Stock, Shares, Outstanding 580,700,000 shares -1.5%
Entity Public Float $55,525,009,946 USD -2.3%
Common Stock, Value, Issued $658,200,000 USD 0.6%
Weighted Average Number of Shares Outstanding, Basic 584,700,000 shares -2.1%
Weighted Average Number of Shares Outstanding, Diluted 585,700,000 shares -2.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $5,883,800,000 USD 11%
Research and Development Expense $1,082,600,000 USD 8.6%
Operating Income (Loss) $1,425,700,000 USD 5%
Nonoperating Income (Expense) $146,900,000 USD -21%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $1,572,600,000 USD 7%
Income Tax Expense (Benefit) $235,800,000 USD 85%
Net Income (Loss) Attributable to Parent $1,367,900,000 USD -67%
Earnings Per Share, Basic 2 USD/shares -66%
Earnings Per Share, Diluted 2 USD/shares -67%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $2,685,600,000 USD -27%
Accounts Receivable, after Allowance for Credit Loss, Current $693,300,000 USD -3.2%
Inventory, Net $1,140,900,000 USD 3.3%
Other Assets, Current $323,400,000 USD 40%
Assets, Current $6,358,900,000 USD -5.5%
Deferred Income Tax Assets, Net $1,099,900,000 USD 24%
Property, Plant and Equipment, Net $1,743,300,000 USD 4%
Operating Lease, Right-of-Use Asset $96,500,000 USD -7.6%
Intangible Assets, Net (Excluding Goodwill) $1,130,800,000 USD 18%
Goodwill $1,768,500,000 USD 10%
Other Assets, Noncurrent $784,800,000 USD 15%
Assets $13,272,200,000 USD 2.3%
Accounts Payable, Current $165,000,000 USD -4.5%
Employee-related Liabilities, Current $437,400,000 USD 40%
Liabilities, Current $1,588,000,000 USD -18%
Operating Lease, Liability, Noncurrent $75,300,000 USD -11%
Other Liabilities, Noncurrent $362,600,000 USD 12%
Liabilities $3,067,200,000 USD -8.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax $250,400,000 USD 0.83%
Retained Earnings (Accumulated Deficit) $14,149,300,000 USD 11%
Stockholders' Equity Attributable to Parent $10,205,000,000 USD 6.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $10,205,000,000 USD 6.2%
Liabilities and Equity $13,272,200,000 USD 2.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $280,400,000 USD
Net Cash Provided by (Used in) Financing Activities $258,000,000 USD -518%
Net Cash Provided by (Used in) Investing Activities $85,300,000 USD 35%
Common Stock, Shares Authorized 1,050,000,000 shares 0%
Common Stock, Shares, Issued 658,200,000 shares 0.6%
Common Stock, Par or Stated Value Per Share 1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $90,000,000 USD 11%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2,694,800,000 USD -27%
Deferred Tax Assets, Valuation Allowance $87,800,000 USD 41%
Deferred Tax Assets, Gross $1,342,100,000 USD 45%
Operating Lease, Liability $102,300,000 USD 16%
Payments to Acquire Property, Plant, and Equipment $56,000,000 USD -14%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $1,370,000,000 USD -67%
Lessee, Operating Lease, Liability, to be Paid $114,200,000 USD 7.9%
Property, Plant and Equipment, Gross $2,480,500,000 USD 8.3%
Operating Lease, Liability, Current $26,800,000 USD 11%
Lessee, Operating Lease, Liability, to be Paid, Year Two $23,300,000 USD 19%
Lessee, Operating Lease, Liability, to be Paid, Year One $26,400,000 USD -1.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $11,900,000 USD 51%
Lessee, Operating Lease, Liability, to be Paid, Year Three $19,100,000 USD 17%
Deferred Tax Assets, Operating Loss Carryforwards $132,100,000 USD 74%
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Unrecognized Tax Benefits $746,900,000 USD 14%
Lessee, Operating Lease, Liability, to be Paid, Year Four $13,200,000 USD 2.3%
Operating Lease, Payments $7,000,000 USD -4.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $36,600,000 USD -4.9%
Share-based Payment Arrangement, Expense $152,800,000 USD 14%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%